TrialVaccine2023

A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women.

Thanyawee Puthanakit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.